• Most Popular
  • Most Shared

Swiss HBM Bioventures to list on Swiss exchange

Mon Jan 14, 2008 1:02am EST

Stocks

   

ZURICH, Jan 14 (Reuters) - Swiss biotechnology investment firm HBM Bioventures Ltd said on Monday it plans to expand its shareholder base through an initial public offering and to list on the SWX Swiss Exchange shortly.

HBM, which currently has investments in more than 40 emerging private and small-cap companies, had net assets at the end of 2007 of 1.1 billion Swiss francs ($997.3 million), or a net asset value per share of 101.93 francs.

Private companies account for 59 percent of HBM's investment portfolio while public companies originating from the private portfolio make up for another 17 percent, other public companies 11 percent and other assets, including cash, 8 percent.

UBS (UBSN.VX) had been retained as the sole global coordinator and sole bookrunner for the planned IPO. Merrill Lynch MER.N, Sal. Oppenheim and Sarasin/Neue Zuercher Bank were co-lead managers, HBM Ventures said in its statement.

(Reporting by Andrew Hurst; Editing by Valerie Lee)



More from Reuters

Photo

New home sales hit seven-month low

WASHINGTON (Reuters) - Consumer spending rose for a second straight month in November as incomes recorded their biggest gain in six months, but a surprise drop in new home sales was a reminder that the economic recovery would be bumpy.

» More Top News
A glass of water taken from a residential well after the start of natural gas drilling in Dimock, Pennsylvania, March 7, 2009. Dimock is one of hundreds of sites in Pennsylvania where energy companies are now racing to tap the massive Marcellus Shale natural gas formation. REUTERS/Tim Shaffer

Not in my watershed: NYC

The biggest U.S. city wants the state to ban one of the most promising sources of U.S. energy -- and also one of the most contentious.  Full Article 

Green Business
Cannabis sativa plant is seen in Buenos Aires, August 21, 2009. REUTERS/Enrique Marcarian
Bernd Debusmann:

Obama, drugs, common sense

American attitudes towards drug prohibition – and above all, punitive laws on marijuana – are changing too fast for policymakers and legislators to ignore.  Commentary 

U.S.